Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Abiraterone + PCUR-101 + Prednisone |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Abiraterone | Zytiga | CB7630 | Hormone - Anti-androgens 54 | Zytiga (abiraterone) inhibits cytochrome P-450c17, resulting in decreased androgen synthesis (PMID: 25560485). Zytiga (abiraterone) is FDA approved for patients with metastatic castration-resistant prostate cancer (FDA.gov). |
PCUR-101 | PCUR101|PCUR 101|PLUMBAGIN | PCUR-101 is a synthetic form of the medicinal plant derivative, plumbagin, which may lead to inhibition of PKCe, STAT3, AKT, and EMT markers, potentially resulting in antitumor activity (NCI Drug Dictionary). | ||
Prednisone | Adasone | Dehydrocortisone | Adasone (prednisone) is a corticosteroid which functions as an immunosuppressant and anti-inflammatory agent and which may stimulate apoptosis in tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04677855 | Phase I | Dutasteride + PCUR-101 PCUR-101 Abiraterone + PCUR-101 + Prednisone | Study of PCUR-101 in Combination With ADT in Patients With mCRPC | Terminated | USA | AUS | 0 |